2 completed, 1 unknown, 1 withdrawn. 2 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow DT56a: new trials by email Literature Review of DT56a trials Research Report on DT56a
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Natural Soybean-derived Femarelle ®for Patients With Non Alcoholic Fatty Liver Disease Femarelle - Nash | Phase 4 | Withdrawn | Hadassah Medical Organization | 2012-01-01 | 2012-08-28 | |
| A Double-Blind Study to Evaluate the Effect of Femarelle® on Menopausal on Vasomotor Symptoms Femarelle, Placebo - Menopause, Hot Flashes | Not applicable | Unknown | Se-cure Pharmaceuticals Ltd. | 200 | 2011-08-01 | 2011-10-12 |
| A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy Femarelle - Vulvo Vaginal Atrophy | Not applicable | Completed | Dr. Lila Nachtigall Rapid Medical Research, New York | 12 | 2011-01-01 | 2017-03-20 |
| Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women DT56a (Femarelle) [Se-cure pharmaceuticals, Dalton, Israel] - Menopause, Thrombophilia | Completed | NYU Langone Health | 32 | 2007-01-01 | 2023-08-22 |
Hot Flashes (1) · Non-alcoholic Fatty Liver Disease (1) · Thrombophilia (1) · Venous Thrombosis (1)
Dr. Lila Nachtigall Rapid Medical Research, New York (1) · Hadassah Medical Organization (1) · NYU Langone Health (1) · Se-cure Pharmaceuticals Ltd. (1)
Israel (2) · United States (2)
Lila Nachtigall, MD (2) · Bari Kaplan, Prof. (1)